Response Biomedical Corporation

98 articles about Response Biomedical Corporation

• Response Biomedical Of Canada Acquired By OrbiMed And China IVD Maker

  6/17/2016

• Response Biomedical Announces The Launch Of The RAMP Dengue Test For Aedes Aegypti And Aedes Albopictus Mosquitoes

  2/19/2016

• Response Biomedical Announces Receipt Of Fifth Milestone In Co-Development Collaboration

  12/31/2015

• Response Biomedical Announces Strategic Alliances In Japan With Alere And Long Time Partner Shionogi

  12/9/2015

• Response Biomedical Announces Notification Of TSX Continued Listing Review

  11/19/2015

• Response Biomedical Announces Third Quarter 2015 Financial Results

  11/13/2015

• Response Biomedical Taps a New CEO

  5/20/2015

• Hangzhou Joinstar And Response Biomedical In $9 Million Deal

  10/17/2014

• Response Biomedical Provides Update On Chinese Distribution Agreement With O&D Biotech Co., Ltd.

  1/3/2014

• Response Biomedical Gets CE Mark for the D-dimer Assay

  11/7/2012

• Response Biomedical Regains Rights to Flu, RSV Tests After Termination of 3M Company Deal

  10/3/2012

• Response Biomedical Taps Jeffrey L. Purvin as New CEO

  4/16/2012

• Response Biomedical Announces Leadership Changes

  10/21/2011

• Response Biomedical Announces Restatement of Financial Statements

  9/30/2011

• Response Biomedical Announces Termination of Sales and Distribution Agreement with Roche Diagnostics Corporation

  9/2/2011

• Response Biomedical Announces Resignation of Chief Executive Officer, S. Wayne Kay

  8/15/2011

• Response Biomedical Announces Second Quarter Results

  8/10/2011

• Response Biomedical Receives Decision Regarding CLIA Waiver for RAMP(R) NT-proBNP Assay for Diagnosis of Heart Failure (HF)

  6/13/2011

• Response Biomedical Enters Into Exclusive Canadian Distribution Agreement with Fisher Scientific Company

  5/4/2011

• Response Biomedical Enters Into Exclusive Canadian Distribution Agreement with Fisher Scientific Company

  5/4/2011